Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion type Assertion NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_head.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion wasGeneratedBy ECO_0000203 NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_provenance.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion wasDerivedFrom befree-20150227 NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_provenance.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion SIO_000772 9042164 NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_provenance.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion evidence source_evidence_literature NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_provenance.
- NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_assertion description "[To elucidate the role of gemistocytes in astrocytoma progression, we assessed the fraction of neoplastic gemistocytes, bcl-2 expression, p53 mutations, p53 immunoreactivity (PAb 1801), and proliferative activity (MIB-1) in 40 low-grade astrocytomas (World Health Organization (WHO) Grade II) with histologically proven progression to anaplastic astrocytoma (WHC Grade III) or glioblastoma (WHO Grade IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557533.RAU_T-e8UuNRg7xlDHeRGHRikf6KPY7MO9HS0HoRMToFY130_provenance.